Zota Health Care Raises ₹350 Crore from Institutional Investors to Fuel Pharmacy Expansion

Zota Health Care Limited (NSE: ZOTA), one of India’s prominent generics pharmacy retail chains, has successfully mobilised ₹350 crore through a Qualified Institutional Placement (QIP) and simultaneously announced the onboarding of former Indian cricket captain Mahendra Singh Dhoni and renowned Bollywood actor Suniel Shetty as brand ambassadors.

Headquartered in Surat, the company issued 22,80,130 equity shares to eligible Qualified Institutional Buyers (QIBs), including foreign portfolio investors, alternative investment funds, and domestic mutual funds, at an issue price of ₹1,535 per share. The QIP witnessed participation from a strong lineup of institutional investors such as Valiant Partners, 360 ONE, Prashant Jain-led 3P Investment Managers, White Oak Capital, Sanshi Fund-I, and Turnaround Opportunities Fund, among others.

Commenting on the successful capital raise, Ketan Zota, Chairman of Zota Health Care Limited, stated that the sustained backing from institutional investors underscores confidence in the company’s long-term growth strategy and scalable business model.

“We deeply appreciate the trust reposed in us by our investors. The participation of several existing shareholders in this QIP is particularly reassuring and reflects their continued belief in our vision and expansion roadmap,” he said.

The funds raised through the QIP will be primarily deployed towards accelerating Zota Health Care’s nationwide retail expansion. The company has set an ambitious target to establish over 5,000 generic pharmacy outlets across India by March 2029, supported by the fresh capital infusion and stable cash flows generated from its mature store base.

“At present, we operate 1,373 Company-Owned Company-Operated (COCO) stores and 880 Franchisee-Owned Franchisee-Operated (FOFO) outlets across the country. Additionally, nearly 400 COCO stores are currently under various stages of development,” Mr. Zota added.

Zota Health Care has also reported consistent improvement in per-store revenue performance, driven by rising consumer awareness and an increasing preference for affordable generic medicines. By offering quality-assured generics at significantly lower prices than branded alternatives, the company continues to strengthen access to essential healthcare for a broader segment of the population.

For more information, visit: https://www.zotahealthcare.com/

Moneycontrol Journalists are not involved in creation of this article.